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Woodchucks infected with woodchuck hepatitis virus (WHV) represent a highly valuable
model of human hepatitis B virus (HBV) infection, chronic hepatitis (CH), and virus
induced-primary liver cancer. Toll-like receptors (TLRs) are important mediators of
immune responses playing pivotal roles in the pathogenesis of viral diseases; however,
their expression profiles in different forms of infection and stages of hepatitis, and
in healthy animals remain essentially unknown. In this study, woodchuck TLRs 1–10
exon fragments were identified and TLR genes transcription quantified in livers, primary
hepatocytes, peripheral blood mononuclear cells (PBMC), and in selected organs during
experimental WHV infection. Among others, liver biopsies from acute hepatitis (AH)
and CH showed significantly augmented expression of the majority of TLRs when
compared to healthy and woodchucks prior to AH, with resolved AH or primary occult
infection. In contrast to the liver tissue, significant upregulation of TLR3, TLR4, and
TLR10, but downregulation of TLR7, characterized hepatocytes derived from livers of
animals with resolved AH accompanied by secondary occult infection. Hepatocytes
from CH showed significantly lower expression or a trend toward suppression of
several TLRs when compared to hepatocytes from healthy animals and woodchucks
with other forms of infection or hepatitis, suggesting that hepatocyte innate immune
response is downregulated during CH. Contrastingly, upregulated transcription of some
TLRs characterized PBMC throughout CH. Our study uncovered that TLR expression
significantly varies between different forms of hepadnaviral infection and whether
infection is accompanied or not by hepatitis. The results showed that the profiles of
TLRs’ expression in circulating lymphomononuclear cells do not mirror accurately those
of livers and hepatocytes from infected animals. These findings are of importance to the
understanding of immune process operating at different sites targeted by virus in the
course of hepadnaviral infection and evaluation of future therapies modifying antiviral
innate responses in the woodchuck model.
Keywords: woodchuck model of hepatitis B, hepadnaviral infection, toll-like receptors, liver, hepatocytes, PBMC,
lymphatic organs
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INTRODUCTION
An estimated 257 million people worldwide have chronic
hepatitis (CH) caused by hepatitis B virus (HBV) and up to
a million die annually as a consequence of infection with this
virus (World Health Organization, 2018). In addition, up to two
billion may have occult infection persisting in the absence of
detectable HBV surface antigen (HBsAg) in serum and clinical
manifestations of liver disease. Symptomatic HBV infection
normally begins as acute hepatitis (AH) that spontaneously
resolves in the majority of adults and, therefore, is denoted as
self-limited AH (SLAH or SL). Importantly, SLAH is followed by
occult HBV persistence, designated as secondary occult infection
(SOI), which progresses in the absence of clinically detectable
serum HBsAg, however, antibodies to HBV core antigen (anti-
HBc), and low levels of circulating HBV DNA and virus
replication in the liver and in peripheral blood mononuclear cells
(PBMC) are identifiable (Michalak et al., 1994; Raimondo et al.,
2008). In 5–10% of cases, AH advances to CH that is accompanied
by serum HBsAg positivity, a high HBV DNA load (up to 1010–
1011 genome copies or virus genome equivalents [vge]/mL) and
by biochemical and histological indicators of protracted liver
inflammation (Ganem and Prince, 2004; McMahon, 2010). CH
can advance to liver cirrhosis and hepatocellular carcinoma
(HCC), which is the major cause of death among patients with
CH type B and has a dismal 5-year survival (Yang and Roberts,
2010; Ryerson et al., 2016). Despite prophylactic vaccines, the
global reservoir of HBV is not substantially decreasing, mainly
due to perinatal virus transmission, many unvaccinated children,
unsafe intravenous drug usage, and migration.
Hepatitis B virus is the prototype of a class of the
smallest, partially double-stranded DNA, non-cytopathic viruses
named hepadnaviruses (Seeger and Mason, 2015). Their unique
characteristic is reverse transcription of genomic DNA to RNA
and RNA back to DNA. As consequence, these viruses are
highly prone to mutations, but they also have features common
with retroviruses regarding the reverse transcription step and
that their DNA irreversibly integrates to the host’s genome
(Nassal, 2008; Mulrooney-Cousins et al., 2014; Levrero and
Zucman-Rossi, 2016). This virus family includes pathogens
infecting human, woodchuck, ground squirrel, tree squirrel,
bat (mammalian viruses), and duck, heron and snow geese
(avian viruses). Among them, woodchuck hepatitis virus (WHV)
displays the greatest compatibility to HBV considering genome
sequence homology (∼65%), antigenic cross-reactivity, spectrum
of organs targeted (i.e., liver and immune system), the patterns
of cellular and humoral immune responses, the sequence of
liver disease progression, and susceptibility to anti-viral therapy
(Michalak, 1998; Tennant et al., 2004; Menne and Cote, 2007;
Roggendorf et al., 2015). Eastern North American woodchucks
(Marmota monax) infected with WHV develop AH that can
advance to CH and HCC or progress from AH to SLAH/SOI
and HCC or develop primary occult infection (POI) that can
also advance to liver cancer (Korba et al., 1989; Michalak
et al., 1999; Michalak, 2000; Mulrooney-Cousins et al., 2014;
Mulrooney-Cousins and Michalak, 2015). Animals inoculated
with very low doses of WHV (<103 virions) develop a primary
asymptomatic persistent infection, designated as POI (Michalak
et al., 2004). This infection coincides with life-long replication of
trace amounts of infectious WHV that occurs in the absence of
detectable serum WHV surface antigen (WHsAg), antibodies to
WHV core antigen (anti-WHc) and antibodies to WHsAg (anti-
WHs). Nonetheless, low levels of virus genome are detectable in
the circulation and infected organs at levels <100–200 vge/ml
and<103 vge/µg of total DNA, respectively, while WHV RNA in
PBMC and livers occurs at estimated levels of<103 vge copies per
µg of total RNA (Michalak et al., 2004; Mulrooney-Cousins et al.,
2014; Mulrooney-Cousins and Michalak, 2015). Interestingly,
WHV-specific proliferative and cytotoxic T cell responses display
similar characteristics in both POI and SOI (Gujar et al., 2008;
Gujar and Michalak, 2009). In contrast to SOI, POI is not
accompanied by virus-specific B cell reactivity and does not
provide protection against reinfection with WHV (Mulrooney-
Cousins and Michalak, 2015). A form of HBV infection similar
to WHV POI has been reported in humans (Zerbini et al.,
2008). Notably, HCC develops in similar frequency (∼20%)
in woodchucks with either SOI or POI, clearly demonstrating
pathogenic importance of these two distinct forms of occult
hepadnaviral persistence (Michalak et al., 1999; Mulrooney-
Cousins et al., 2014). Overall, WHV infection in woodchucks
represents the closest pathogenic model of HBV infection,
hepatitis B and HBV-associated HCC. It also is the most valuable,
naturally occurring system for in vivo evaluations of novel anti-
HBV and anti-HCC therapies, including those based on the
approaches modifying hepatic innate immunity involving Toll-
like receptors (TLRs).
Due to the non-cytopathic nature of hepadnaviruses, virus-
triggered immune responses are primarily responsible for
induction of hepatocyte injury and liver inflammation, as well
as for resolution or persistence of hepatitis. TLRs are innate
sensors belonging to the pattern recognition system identifying
conserved motifs of microorganisms (Rock et al., 1998; Aderen
and Ulevitz, 2000). In microbial infections, they sense non-
self components and transmit signals that activate a range of
cytokines downstream. These cytokines subsequently trigger cells
of the innate immune system and activate effectors of the adaptive
immune response, i.e., T and B cells (Mencin et al., 2009;
Blasius and Beutier, 2010; Hua and Hou, 2013). Therefore, the
interaction between virus and TLRs is considered critical to
viral pathogenicity, particularly in infections with non-cytopathic
viruses.
As indicated, HBV and WHV can initiate different forms of
infection and the induced hepatitis may advance to chronic liver
disease and HCC or resolve, although virus never completely
clears (Michalak et al., 1994, 1999). In this context, identification
of the TLR expression profiles in virus-targeted cells and organs
would benefit delineation of the immune processes contributing
to the establishment and endurance of the distinctive forms
of infection and liver injury. The woodchuck model of HBV
infection is uniquely positioned to advance knowledge in this area
and it has been utilized, at least to some degree, for this purpose
(Zhang et al., 2012; Meng et al., 2016). This is well examplified
in studies on the oral TLR7 agonist GS-9620, which antiviral
effects has been shown in woodchuck and chimpanzee models of
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CH type B, and its testing advanced to clinical trials suggesting
that activated both innate and adaptive immunity contribute to
antiviral response (Gane et al., 2015; Menne et al., 2015; Boni
et al., 2018; Niu et al., 2018). Nevertheless, expression of the entire
family of TLR genes in sequential forms of WHV infection and
stages of coinciding hepatitis, as well as in healthy animals, has
not yet been determined. The main goal of this study was to
systematically determine the transcription profiles of TLRs 1 to
10 during the course of experimental infection and at the sites
naturally targeted by hepadnavirus, i.e., liver and immune system,
exemplified in this study by PBMC. For this purpose, serial
liver biopsies and PBMC samples from woodchucks followed
from the pre-infection period (healthy) throughout pre-acute
(PreAH) and acute hepatitis (AH) to SLAH followed by SOI or
CH, and from animals with long-term POI were investigated.
We also aimed to recognize how the TLR expression profiles
may differ between livers and primary hepatocytes isolated from
these livers in different forms of infection and stages of hepatitis.
This study was specifically focused on determination of the
transcriptional activity of multiple TLR genes and generated
wealth of information which should provide a direction and
benefit further delineation of unique characteristics of the innate
immune responses operating in successive stages and at different
sites of hepadnaviral infection. This is particularly important
since specific antibodies against the majority of woodchuck TLRs
and affiliated molecules mediating the downstream effects of their
activation or suppression remain unavailable.
MATERIALS AND METHODS
Ethics Statement
All animal experiments and the animal maintenance protocols
were performed in compliance with the Institutional
Animal Care Committee at Memorial University, St. John’s,
Newfoundland and Labrador, Canada that follows the guidelines
and is accredited by the Canadian Council on Animal Care
in Science. The approved protocol identification number is
13-159-M.
Animals and Categories of WHV
Infection and Hepatitis
Woodchucks (Marmota monax) were maintained in the
Woodchuck Viral Hepatitis Research Facility at the Health
Science Center, Memorial University, St. John’s, NL, Canada.
Healthy animals were WHV-naive, as ascertained by negative
results of serum testing for WHsAg and anti-WHc (Michalak
et al., 1999). They also were negative for WHV DNA in
serum and liver biopsies by high-sensitivity polymerase chain
reaction (PCR)-based assays (Michalak et al., 1999, 2004). WHV-
naïve woodchucks infected with WHV doses (≥>106 DNA-ase
digestion-protected virions) at one or 2-years of age developed
AH accompanied by high levels of serum WHV DNA and
WHsAg, as well as elevated biochemical indicators of liver injury,
such as serum sorbitol dehydrogenase (SDH) (Gujar et al., 2013).
If serum WHsAg cleared prior to 6 months post-infection, a
diagnosis of SLAH was made. As indicated previously, SLAH
is followed by the lifelong persistence of WHV DNA and anti-
WHc reactivity in serum, while virus replication continues at
low levels in the liver and the immune system (Michalak et al.,
1999, 2004). This form of asymptomatic infection was designated
as SOI (Mulrooney-Cousins and Michalak, 2015). If WHsAg
persists in circulation for longer than 6 months, CH is diagnosed.
CH normally coincides with high levels of serum WHV DNA (up
to 1010–1011 vge/mL) and increased levels of enzymes indicative
of liver injury. Woodchucks with CH at a high frequency (≥85%)
develop HCC (Popper et al., 1981; Michalak, 1998). In the current
study, 4 of 10 woodchucks with CH developed HCC. It should
be mentioned that a non-tumorous part of hepatic tissue was
used only for investigation. For the purpose of this study, PreAH
refers to the phase of infection after inoculation with a high
dose of WHV (≥106 virions) but prior to establishment of
AH. Regarding POI, woodchucks infected with WHV at doses
of less than 103 virions develop entirely asymptomatic (silent)
infection that is accompanied by the lack of serological markers
of infection, such as WHsAg and anti-WHc (Michalak et al., 2004;
Mulrooney-Cousins and Michalak, 2015). However, WHV DNA
is detectable in serum, PBMC and in the lymphatic (immune)
system, and the virus with time may spread to the liver without
induction of hepatitis, as reported (Michalak et al., 2004; Gujar
and Michalak, 2009; Mulrooney-Cousins et al., 2014). The mean
WHV levels in plasma, liver and PBMC of the animals with
different form of infection or/and hepatitis investigated in this
study were shown in Supplementary Table S1. The samples were
collected at the time of acquisition of liver biopsy or autopsy
tissue, which was usually obtained at 6–12 month intervals.
In addition to immunovirological and biochemical markers
measured in circulation, histological examination of liver biopsies
obtained by laparotomy and at autopsy served to diagnose the
status liver disease and its progression or resolution (Michalak
and Lin, 1994; Michalak et al., 1999; Mulrooney-Cousins et al.,
2014; Mulrooney-Cousins and Michalak, 2015).
Samples Investigated
This study had three interconnected parts. In the first part, tissue
samples from liver, spleen, bone marrow and PBMC collected
at autopsy from 16 animals were analyzed. This study group
included 4 healthy woodchucks (between 2 and 4 years of age),
7 with SLAH/SOI, and 5 with WHsAg-positive CH of which two
finally developed HCC (Supplementary Table S2). Samples from
animals with SLAH/SOI were collected from 10 to 36 months
post-infection (m.p.i.) with WHV, while those from woodchucks
with CH from 20 to 42 m.p.i. For the second part of the study,
livers and hepatocytes isolated from these livers were examined.
The autopsy livers and paired hepatocytes were obtained from
26 animals, including 5 healthy (between 2 and 4 years of age),
4 within the PreAH phase acquired before or at 4 weeks p.i.
(w.p.i.), 8 with SLAH/SOI obtained at 12–48 m.p.i., 6 with CH
collected from 18 to 48 m.p.i., and 3 with POI obtained between
12 and 66 m.p.i. (Table 1). In the third part, sequential liver
biopsies procured from 28 woodchucks were analyzed for TLR
1–10 expression, including 20 samples from healthy, 4 from the
PreAH stage obtained prior to or at 4 w.p.i., 8 from AH obtained
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TABLE 1 | Woodchuck samples from different forms of experimental WHV infection and stages of hepatitis examined in this study.
Sample type Total animal number Sample number according to category of infection or hepatitis Total sample number
Healthy PreAH AH SLAH/SOI CH POI
Autopsy liver 26 5 4 0 8 6 3 26
Hepatocytes 26 5 4 0 8 6 3 26
Liver biopsy 28 20 4 8 3 12 14 61
PBMC 4 11 8 18 6 8 0 51
PreAH, pre-acute hepatitis; AH, acute hepatitis; SLAH/SOI, self-limited acute hepatitis followed by secondary occult infection; CH, chronic hepatitis; POI, primary occult
infection.
between one and 6 m.p.i., 3 from SLAH/SOI acquired at 12–
48 m.p.i., 12 from CH collected between 18 and 48 m.p.i., and 14
from POI taken between 12 and 66 m.p.i. Sixty-one liver biopsies
in total were investigated (Table 1). Non-HCC liver tissue was
investigated only. Finally, 51 sequential PBMC samples were
collected from 4 woodchucks prior to and throughout the course
of WHV infection (Table 1). Two of the woodchucks developed
AH and subsequently resolved hepatitis and established SOI (i.e.,
SLAH/SOI), while two others progressed from AH to CH and
finally developed HCC.
Cell Isolations
Hepatocytes were isolated from autopsy livers by the two-step
collagenase perfusion technique, as described in the previous
works from this laboratory (Michalak et al., 1989; Michalak and
Lin, 1994; Churchill and Michalak, 2004). Hepatocyte purity
was consistently greater than 98% as determined by phase-
contrast microscopy and confirmed by flow cytometry after
staining for asialoglycoprotein receptor (ASGPR) and by RT-
qPCR assays designed for detection of potential immune cell
contaminations (Diao et al., 1998; Guy et al., 2010, 2011). PBMC
were isolated by density gradient centrifugation, as reported
(Gujar and Michalak, 2005). Their viability was determined by
trypan blue dye exclusion and normally exceeded 98%. All cells
were stepwise cooled and subsequently frozen. They were stored
in liquid nitrogen prior to analysis.
RNA Extraction and Transcription
Total RNA was isolated using TRIzol reagent (Invitrogen Life
Technologies, Burlington, ON, Canada) from approximately
100 mg of tissue, 5 × 106 hepatocytes and 0.5–1 × 107
PBMC. Each series of RNA extractions were done in parallel
with mock extraction using sterile water instead of test
samples as a contamination control. In order to remove DNA
potentially tainting samples, RNA aliquots were treated with
amplification grade DNase I following the manufacturer’s
protocol (Invitrogen). RNA concentration and purity were
determined by an NanoDrop 2000 instrument (Thermo
Scientific, Waltham, MA, United States), while RNA integrity
by an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA, United States). Following the analysis, an RNA
Integrity Number (RIN) was generated for each RNA sample.
Samples with RIN 8 or above were used in the study. If RIN
was below 8, RNA extraction was repeated. Each RNA sample
(2 µg) was transcribed to cDNA as reported (Pham et al.,
2004).
Amplification of Woodchuck TLR
Sequences and Their Cloning
Toll-like receptor forward (sense) and reverse (anti-sense)
oligonucleotide primers were designed to amplify woodchuck
TLR1, TLR2, and TLR4 to TLR10. Primers for woodchuck
TLR3 (GenBank accession number EU586552) were previously
published (Zhang et al., 2009). Our primers were generated using
aligned TLR nucleotide sequences from a variety of mammalian
species deposited in the Entrez Nucleotide Database1. Complete
protein-coding sequences (exons) were queried and aligned
using Sequencher v4 software (Gene Codes Corporation,
Ann Arbor, MI, United States). The consensus sequences
were constructed and primers were designed to amplify TLR
fragments in regions of the highest interspecies homology.
These primers were used for the initial amplification of
woodchuck TLR 1–10 by end-point polymerase chain reaction
preceded by reverse transcription step (RT-PCR) using cDNA
derived from spleens and livers of two healthy woodchucks.
In the following step, PCR products were purified and cloned
using a TOPO TA cloning system (Invitrogen). Mini-scale
preparations from individual clones were generated, DNA
isolated and subjected to restriction enzyme digestion. The
inserts of interest carrying exon DNA sequence for each of
the woodchuck TLR genes were bidirectional sequenced to
confirm the presence of TLR sequence. Then, large stocks of
plasmids containing confirmed woodchuck TLR sequences were
produced.
Woodchuck-Specific TLR 1–10
Real-Time RT-qPCR Assays
Toll-like receptor primers used for the initial amplification of
woodchuck TLR 1–10 fragments were redesigned, if required,
based on the confirmed woodchuck sequences generated to be
100% woodchuck compatible. The final primer sequences used in
this study are listed in Table 2. Each TLR primer pair underwent
series of experiments determining optimal conditions for real-
time (quantitative) RT-PCR (i.e., RT-qPCR) amplification. Each
individual reaction included the cDNA equivalent of 50 ng
of total RNA tested and 5 pmol of each respective primer.
1http://www.ncbi.nlm.nih.gov/nuccore
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TABLE 2 | Woodchuck TLR 1–10 and housekeeping gene primer sequences used for quantitative expression analyses.
Gene Primer sequence (5′–3′ orientation) Length (bp) Predicted amplicon size (bp) Sensitivity (copies/reaction)
TLR-1 + CAT TTG ATG CCC TGC CTA TAT G 22 435 10
– TAT GCC AAA CCA GCT GGA GGA T 22
TLR-2 + TGA CTC TCC CTC CCA C 16 235 10
– GTC GTA GCA GAT GTC CC 17
TLR-3 + AGG GAC TTT GAG GCA GGT GT 20 230 100
– CGC AAA CAG AGT GCA TGG T 19
TLR-4 + AAG GTT TCC ATA AAA GCC G 19 193 100
– AGT AGG CGG TAC AAC TC 17
TLR-5 + GCC TTG AAG CCT TCA GTT ATG C 22 76 100
– CCA ACC ACC ACC ATG ATG AG 20
TLR-6 + GCC CAA ACC TGT GGA ATA TCT CA 23 424 10
– CAA AGA ATT CCA GCT AAC ATC CA 23
TLR-7 + GCC TGT TCT GTA AAG G 16 471 100
– ACT CCC GGA ATG ATT G 16
TLR-8 + CAC ATC CCA AAC TTT CTA TGA TG 23 100 100
– CTC TTC AAG GTG GTA GCG C 19
TLR-9 + TGG TAC TGC TTC CAC CT 17 358 10
– ACA CCA CGA CAT CCT T 16
TLR-10 + GAT GGT CAG ATT CAT ACA TCT G 22 124 10
– ATG ATG GCC ACA ATG GTG AC 20
HPRT + TGA CAC TGG CAA AAC AAT GCA 21 96 10
– GGT CCT TTT CAC CAG CAA GCT 21
β-actin + ATC ATG TTT GGG ACC TTC AA 20 350 10
– CAT CTC TTG GTC GAA GTC CA 20
Reactions were performed using SsoFast EvaGreen Supermix
(Bio-Rad Laboratories, Mississauga, ON, Canada) in a 96-
well plate format and the Light Cycler 480 System (Roche
Diagnostics, Mannheim, Germany). The sensitivity of detection
for each TLR was determined using serial 10-fold dilutions of
plasmid carrying respective woodchuck TLR sequence insert.
All TLR primer pairs were able to detect at least 100 copies
of a given TLR per reaction. TLR1, TLR2, TLR6, TLR9,
and TLR10 were detectable at a limit of detection (LOD) of
10 copies/reaction (Table 2). Amplification of serial dilutions
of known plasmid concentrations allowed for the generation
of a standard curve for absolute quantification of a given
TLR expression. Samples with Ct values that fell within the
standard curve range were assigned a copy number for the TLR
tested.
The layout for each 96-well plate was designed to include
all appropriate controls in addition to test samples, i.e., (1)
All components of the amplification reaction except the cDNA
template (no template control, NTC); (2) Sterile water instead
of RNA template when reverse transcribing RNA to cDNA
(negative RT, mock); (3) Internal controls from livers and spleens
of two healthy woodchucks carrying known copy numbers
of each TLR 1–10, and (4) Serial dilutions 1 × 101 to
1 × 106 copies of the appropriate recombinant TLR fragment as
quantitative standards. The NTC served for excluding potential
contamination in the PCR reagents, while the mock controlled
for any potential contamination carryover from RT reagents.
Amplifications of all test and control samples were done in
triplicate.
Determination of TLRs’ Expression
Expression of woodchuck β-actin was evaluated as housekeeping
gene in the first phase of the study when profiles of TLRs’
expression in woodchuck autopsy samples were compared
(Supplementary Figure S1). However, β-actin was found to be
unreliable when comparing TLRs transcription between livers
and hepatocytes (Supplementary Figure S2). Therefore, TLR
expression was subsequently normalized to that of hypoxanthine-
guanine phosphoribosyl transferase (HPRT). HPRT was chosen
based on the previous studies analyzing the expression of multiple
housekeeping genes which concluded that HPRT is one of the
most stably transcribed genes in human and rat livers and
hepatocytes (Nishimura and Naito, 2005; Chen et al., 2006; Tsaur
et al., 2013). Thus, the absolute TLR expression values were
divided by the absolute expression value of HPRT or β-actin.
DNA Extraction and WHV Quantification
DNA from 100 to 400 µL of serum or plasma and from liver,
spleen, bone marrow, and PBMC was extracted by the proteinase
K-phenol-chloroform method (Michalak et al., 1999; Mulrooney-
Cousins et al., 2014). Considering serum or plasma samples,
only samples collected at the time of acquisition of liver tissue
at biopsy or autopsy or PBMC were examined. WHV DNA
was quantified by real-time PCR (sensitivity, 10–100 vge/mL)
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using DNA equivalent to 25 µL of plasma or 400 ng of total
DNA from cells or tissues, and WHV C and X gene primers
(Mulrooney-Cousins et al., 2014; Chauhan et al., 2017). When
applicable, WHV DNA was semi-quantified by direct and, if
negative, nested PCR/nucleic acid hybridization (NAH) using
primers and conditions reported (Michalak et al., 1999; Coffin
et al., 2004; Mulrooney-Cousins et al., 2014). Mock extractions
and respective nucleic acid preparations from WHV-positive and
WHV-negative woodchuck livers or PBMC were included as
controls. NAH analysis of PCR products was routinely performed
to verify the specificity of virus detection and the validity of
controls (Michalak et al., 1999; Coffin et al., 2004; Mulrooney-
Cousins et al., 2014).
Statistical Analysis
Results were analyzed by paired or unpaired Student’s-t test,
where applicable, using GraphPad Prism software (Graph Pad
Software Inc., San Diego, CA, United States). A paired t-test was
used when analyzing TLR 1–10 mean expression values in livers
and hepatocytes derived from those livers. Differences between
experimental conditions were considered to be significant when
two-sided P-value from analysis of mean expression levels was
equal or lower than 0.05. Data bars marked with ∗ were significant
at P < 0.05, ∗∗ at P ≤ 0.01, ∗∗∗ at P ≤ 0.001, and ∗∗∗∗ at
P ≤ 0.0001.
Accession Numbers
Woodchuck TLR partial gene sequences identified in the current
study were deposited in GenBank. Their accession numbers are
KY468972 to KY468981 for TLR1 to TLR10, respectively.
RESULTS
Woodchuck TLRs 1–10 Sequence
Compatibility With Human TLR
Sequences
Alignment of amino acid (aa) sequences predicted from
woodchuck TLR 1–10 nucleotide sequences identified in this
study with respective aa sequences of human TLRs 1–10 showed
that, except for TLR1 and TLR6, the sequences coded for the
Toll-interleukin 1 receptor (TIR) domain of the TLR proteins.
Hence, woodchuck TLR3 (aa 790–870), TLR4 (aa 710–810),
and TLR5 (aa 770–800) aligned with a region located within
the TIR domain of human TLR3 (GenBank accession number
ABC86910), TLR4 (GenBank AAF05316) and TLR5 (GenBank
AAI09119), respectively. Woodchuck TLR8 (aa 880–910) and
TLR9 (aa 840–1030) spanned the cytoplasmic region located
upstream from the TIR domain and overlapped with the TIR
domain of human TLR8 (GenBank AAZ95441) and TLR9
(GenBank AAZ95521). Further, woodchuck TLR2 (aa 540–670),
TLR7 (aa 790–1030) and TLR10 (aa 520–693) corresponded to
the extracellular, transmembrane and TIR domains of human
TLR2 (GenBank AAH33756), TLR7 (GenBank AAZ99026) and
TLR10 (GenBank AAY78491), respectively. In contrast, TLR1
(aa 120–270) and TLR6 (aa 280–420) were homologous to the
cytoplasmic domain of human TLR1 (GenBank AAH33756)
and TLR6 (GenBank BAA78631). This was expected, since
knowing that the TIR domains of TLR1 and TLR6 share
high sequence homology, making them undesirable for specific
priming (Plain et al., 2010), we designed primers for the
regions sharing the least homology. This allowed for specific
quantification of woodchuck TLR1 and TLR6 expression in our
study.
We acknowledge that when this study was in progress, partial
sequences for woodchuck TLR3 (GenBank EU586552.1), TLR4
(GenBank EU586553.1), TLR7 (GenBank EU586554.1), TLR8
(GenBank EU586555.1), and TLR9 (GenBank EU586556.1) were
reported (Zhang et al., 2009). Later, a partial sequence of
woodchuck TLR2 (GenBank HQ446273.1) and the complete
sequence coding for woodchuck TLR7 (GenBank KT013099.1)
also became available. Nonetheless, when these sequences were
compared to the woodchuck TLR gene fragments identified in
the current study all, but TLR3 and TLR7, were either fully
or partially unique, and have not yet been previously reported.
For the GenBank accession numbers of the woodchuck TLR
sequences identified in this study, see section “Materials and
Methods”.
TLRs 1–10 Expression in Livers,
Lymphatic Tissues and PBMC of Healthy
Woodchucks
Liver, spleen, bone marrow and PBMC collected at autopsy from
four healthy, WHV-naïve adult woodchucks (Supplementary
Table S2) were evaluated for expression of TLRs 1–10 by assays
applying real-time RT-qPCR, as detailed in section “Materials and
Methods”. To enable comparisons between tissues, expression of
individual TLRs was normalized to the expression of woodchuck
HPRT and β-actin (Figure 1 and Supplementary Figure S3,
respectively). Both house-keeping transcripts were detectable by
RT-qPCR with a LOD of 10 copies per reaction (Table 2).
The expression of individual TLRs was variable depending
on the class of TLR and organ investigated, and was often
influenced by housekeeping gene used for normalization of their
expression. When expression of individual TLRs were adjusted
to that of HPRT, liver TLR5 and TLR7 were transcribed at
significantly greater levels than those in PBMC and spleen
(Figure 1). In addition, TLR8 was expressed at a significantly
higher level in spleen than liver but not in PBMC, while
TLR1 transcription remained significantly higher in PBMC than
in liver or spleen (Figure 1). Notably, bone marrow samples
did not express detectable levels of HPRT. For comparison,
when related to β-actin expression, normal liver tissue displayed
significantly greater mean levels of TLR3, TLR4, TLR5, and
TLR7 than spleen, bone marrow or PBMC, while hepatic mean
TLR2 transcription was meaningfully higher than that in spleen
and PBMC (Supplementary Figure S3). TLR6 expression was
significantly higher in PBMC than bone marrow, but displayed
at comparable levels in bone marrow, spleen and liver tissues.
Further, TLR8 was ubiquitously expressed in the tissues examined
and PBMC. Only TLR10 was transcribed in the spleen at
significantly higher level than in liver or bone marrow (P< 0.05),
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FIGURE 1 | Distribution of TLR 1–10 expression in liver, spleen, bone marrow and PBMC obtained from four healthy adult woodchucks. Autopsy tissues and PBMC
were evaluated for transcription of individual woodchuck TLRs by qRT-PCR assays as outlined in section “Materials and Methods”. The TLR expression was
normalized to expression of woodchuck HPRT. The results are presented as relative mean values ± SEM. Statistically significant differences between data bars are
marked with ∗, ∗∗ or ∗∗∗ as explained in section “Materials and Methods”. TLR1 was not detectable in liver, spleen and bone marrow but was at low copy numbers in
PBMC. HPRT was not detectable in bone marrow samples and therefore is not shown.
but at similar mean level as in PBMC when adjusted to β-actin
expression (Supplementary Figure S3). TLR1 expression was
found only in PBMC, while that of TLR5 only in the liver but
not in other samples examined (Supplementary Figure S3).
Comparative Analysis of TLRs 1–10
Expression in Woodchucks With
Resolved Acute Hepatitis and Chronic
Hepatitis
Since virological and immunological features, as well as a degree
of hepatocellular damage and liver inflammation significantly
vary between different forms of WHV infection, TLRs 1–10
expression was assessed in autopsy liver, spleen, bone marrow,
and PBMC from two opposed forms of WHV-induced liver
injury. Thus, samples were obtained from animals with SLAH
(abbreviated also as SL) or CH (Supplementary Table S2).
SLAH is naturally followed by lifelong SOI (i.e., SLAH/SOI) and
accompanied by histologically evident intermitted minimal and,
rarely, mild hepatitis (Michalak et al., 1999). The mean WHV
levels in livers and PBMC of SLAH/SOI animals investigated in
this part of the study (n = 7) were 1.0 × 103 (SEM ± 5.4 × 102)
and 2.0 × 103 (SEM ± 1.1 × 102) vge/µg DNA, respectively.
Woodchucks with CH demonstrated histologically evident mild
to severe chronic liver inflammation which coincided with
continuous presence of WHsAg and high loads of WHV DNA in
serum (n = 5). The mean WHV level in livers of these animals was
2.8 × 107 (SEM ± 2.3 × 107), while that in PBMC was 4.2 × 101
(SEM ± 2.4 × 101) vge/µg DNA. The expression of TLRs was
compared to that in the respective tissues or PBMC from healthy
animals (n = 4) (Supplementary Table S2). Since HPRT was
not transcribed at measurable levels in woodchuck bone marrow,
β-actin was used for normalization of TLRs’ expression for this
part of the study (Supplementary Figure S4).
Considering the liver, a significant downregulation in the
expression of TLR5 in animals with CH comparing to that in
animals with SLAH/SOI (P < 0.05) and healthy woodchucks
(P < 0.001) was found. Furthermore, the mean expression of
TLR9 in hepatic tissue of woodchucks with CH was significantly
greater than that in healthy animals (P < 0.05) and tended to
be higher, but not at a statistically significant level, than that
in animals with SLAH/SOI. In addition, TLR9 mean expression
showed a similar trend as TLR6 in CH liver. The transcription
levels of all other TLRs were not meaningfully different between
these three study groups (Supplementary Figure S4).
Among lymphoid tissues and PBMC, the spleen most
frequently demonstrated upregulated expression of individual
TLRs which coincided with serologically evident chronic
hepatitis (Supplementary Figure S4). Thus, the expression
of TLR2 was significantly augmented in animals with CH
comparing to those with SLAH/SOI (P < 0.05) or healthy
woodchucks (P ≤ 0.001). Moreover, TLR4 (P ≤ 0.001), TLR8
(P < 0.05), and TLR9 (P < 0.05) were transcribed at significantly
greater levels in spleens of woodchucks with CH than in those of
healthy animals. Also, it of notice that TLR8, TLR9, and TLR10
showed the same expression trends CH spleens. In addition, the
TLR mean expression levels tended to be higher in animals with
SLAH/SOI comparing to those in healthy, but without achieving
statistical significance.
Considering PBMC, the level of TLR1 expression was
significantly higher in SLAH/SOI comparing to that in
either CH or healthy woodchucks (P < 0.05). Also, the
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FIGURE 2 | TLR 2–10 expression profiles in livers and hepatocytes isolated from these livers obtained from healthy and WHV-infected woodchucks. Transcription
levels of TLR 2–10 in livers and hepatocytes were acquired from healthy animals (n = 5) and woodchucks with pre-acute phase of hepatitis (PreAH; n = 4), after
recovery from acute hepatitis during secondary occult infection (SLAH; n = 8), chronic hepatitis (CH; n = 6) or in the course of primary occult infection (POI) (n = 3).
TLRs’ expression was normalized against HPRT expression and presented as relative mean values ± SEM. (A) Expression of TLRs 2–10 in hepatocytes obtained
from distinct forms of WHV infection and stages of hepatitis. (B) Expression levels of each individual TLR in livers of WHV-naïve, healthy animals and in primary
hepatocytes derived from these livers. Differences between data bars are marked as indicated in section “Materials and Methods”. TLR1 transcription was evaluated
but not detected.
expression of TLR3 was greater in SLAH/SOI than CH
(P < 0.05), but not meaningfully different from that in health
animals (Supplementary Figure S4). There were no statistically
significant differences between the groups in the mean expression
levels of TLRs 1–10 in samples of bone marrow.
Overall, comparative analysis of the TLR’s expression in liver
and three different locations within the immune system from
SLAH/SOI, CH and healthy animals showed distinct profiles
regarding transcription of individual TLRs when normalized
to β-actin. The differences were most pronounces in liver and
spleen, less in PBMC, and not apparent in bone marrow.
Expression of TLRs 2–10 in Livers and
Isolated Hepatocytes
It became apparent that determination of expression of
housekeeping genes was important to ensure that they were
detectable and at approximately similar levels across the
organs and cells examined to facilitate comparative analysis
of TLR expression. Thus, the preceding evaluations included
assessment of expression of woodchuck β-actin and HPRT
in livers (n = 26) and hepatocytes isolated from these livers
(n = 26) in healthy (n = 5) and WHV-infected (n = 21)
woodchucks. The results showed that β-actin was expressed at
significantly higher mean levels in liver tissue samples (P < 0.05)
than in isolated hepatocytes (Supplementary Figure S2A).
In contrast, HPRT was transcribed at comparable levels in
both hepatic tissue (n = 87) and hepatocytes (n = 26).
It is of note that transcription of HPRT was significantly
greater in PBMC (n = 51) than in liver tissue samples
(n = 87) (P < 0.0001) or hepatocytes (n = 26) (P < 0.0001)
(Supplementary Figure S2B). Therefore, TLR expression in
relation to HPRT in livers and hepatocytes were compared to
each other in all forms of WHV infection and hepatitis, while
that in PBMC to livers and hepatocytes from healthy woodchucks
only.
Since liver parenchyma is comprised by 85% of hepatocytes,
we aimed to assess whether primary hepatocytes express similar
profiles of TLR 1–10 expression as the livers during WHV
infection. For this part of the study, paired liver tissue samples
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FIGURE 3 | Comparative expression of individual TLRs in livers or hepatocytes
isolated from these liver within each group with the same form of infection or
hepatitis and in livers or hepatocytes from a particular group across all study
groups. Differences between data bars reflecting relative mean expression
values ± SEM are marked as indicated in section “Materials and Methods”.
and purified hepatocytes prepared from these livers were
obtained from 26 animals, including 5 healthy woodchucks (four
male and one female), 4 animals infected with WHV but prior
to diagnosis of AH (i.e., PreAH) (three male and one female),
8 woodchucks which resolved AH and established SOI (i.e.,
SLAH/SOI) (two male and six female), 6 during CH (four male
and two female), and 3 in the course of POI (two male and one
female) (Table 1).
Considering hepatocytes alone, when compared to
hepatocytes from CH, hepatocytes from SLAH/SOI showed
upregulated mean expression of TLR3 (P < 0.05), TLR7
(P < 0.01) and TLR10 (P < 0.05), while those from healthy
animals demonstrated significantly higher levels of TLR5
(P < 0.05) (Figure 2A). Hepatocytes from woodchucks with
CH also displayed significantly lower mean expression levels
of TLR7 and TLR8 when compared to animals with PreAH
(P < 0.01) and POI (P < 0.01), respectively. In addition, the
mean expression of TLRs 2–4, 6, and 8–10 in hepatocytes
from healthy animals and TLRs 2, 4, 6, 8, and 9 in hepatocytes
from SLAH/SOI tended to be higher than in hepatocytes from
CH, but these differences were not statistically significant
(Figure 2A). Overall, hepatocytes from animals with CH were
characterized by significant downregulation or trend toward
suppression of transcription of almost all TLRs when compared
to hepatocytes from other forms of WHV infection and from
healthy animals.
Transcription levels of TLRs 1–10 were also compared
between livers and hepatocytes isolated from these livers.
Considering healthy animals, only the mean level of TLR7
expression was significantly downregulated in hepatocytes
comparing to that in the total liver tissue (P < 0.01)
(Figure 2B). However, although without reaching level of
statistical significance, mean expression levels of all other TLRs
were upregulated in hepatocytes when compared to normal
liver tissue. This indicated that the TLR expression profile was
modified in hepatocytes following isolation, particularly that of
TLR7. This result should be taken under consideration when
interpreting data on TLRs’ expression from experiments utilizing
primary hepatocytes.
Animals with SLAH/SOI also demonstrated a significantly
greater mean expression level of TLR7 in livers than hepatocytes
(P < 0.01) (Figure 3). Conversely, livers from woodchucks with
SLAH/SOI displayed significantly decreased mean expression of
TLR3 (P < 0.05), TLR4 (P < 0.05), and TLR10 (P < 0.05)
when compared to hepatocytes derived from these livers.
Furthermore, TLR8 expression was also found at significantly
lower mean level in livers than hepatocytes (P < 0.001)
in animals with POI (Figure 3). There were no significant
differences in mean expression of TLR2, TLR6, and TLR9
between livers and hepatocytes from healthy or WHV-infected
woodchucks (Figure 3). However, there was apparent consistency
in augmented, but not statistically different, expression of
TLR2, TLR4, TLR6, and TLR 8–10 in hepatocytes over livers
from SLAH/SOI and healthy woodchucks. This extended to
TLR6 and TLR 8–10 for hepatocytes versus livers from the
PreAH phase. Finally, TLR1 was not detected in any of
the liver and hepatocyte samples. In general, the results
showed that while healthy animals and woodchucks with
PreAH, CH or POI showed a statistically significant difference
in expression of only one particular TLR between livers
and hepatocytes derived from these livers, animals with
SLAH/SOI demonstrated highly pronounced differences in this
regard.
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FIGURE 4 | Transcription levels of TLR 2–10 in sequential liver biopsies and
liver tissue samples collected at autopsy from woodchucks with different
forms of WHV infection and hepatitis. Liver samples were obtained from
healthy woodchucks (n = 25) and animals with pre-acute phase of hepatitis
(PreAH; n = 8), during acute hepatitis (AH; n = 8), following resolution of acute
hepatitis (SLAH; n = 11), during chronic hepatitis (CH; n = 18) or in the course
of primary occult infection (POI; n = 17). TLR1 was not detectable. For more
details, see the legend to Figure 2 and section “Materials and Methods”.
Expression Profiles of TLRs 2–10 in
Sequential Liver Biopsies Acquired Prior
to and During Experimental WHV
Infection
Liver tissue samples acquired at biopsies of healthy animals,
throughout the course of WHV infection induced in these
animals and during autopsy, at the end of follow-up, were
investigated. There were in total 25 liver tissue samples collected
from healthy woodchucks, 8 from the PreAH phase, 8 from AH,
11 from SLAH/SOI, 18 from CH, and 17 from POI (Table 1).
When compared to the healthy, pre-infection stage, the PreAH
phase was characterized by significantly greater expression
of TLR3 (P < 0.01) (Figure 4). PreAH livers also showed
significantly higher transcription levels of TLR3 (P< 0.01), TLR5
(P< 0.05) and TLR7 (P< 0.05) when compared to the SLAH/SOI
phase, while TLR8 (P < 0.05) was upregulated when compared
to livers from animals with POI. In addition, although not
significantly, PreAH livers showed increased expression of TLR
4–7 comparing to livers of healthy animals, TLR2, TLR4, TLR6,
and TLR8 when compared to livers from the SLAH/SOI phase,
and TLR 2–5 and TLR 7–8 when compared to livers from POI.
In contrast, TLR9 appeared to be downregulated in PreAH livers
versus healthy livers and those from animals with SLAH/SOI,
while upregulated in SLAH/SOI versus POI. Analysis of liver
biopsies from the AH stage showed significant upregulation
of several TLR genes, specifically, TLR3 (P < 0.01), TLR4
(P = 0.01), TLR6 (P < 0.05), TLR7 (P = 0.01), TLR8 (P < 0.01),
TLR9 (P < 0.05), and TLR10 (P < 0.01) when compared to
their expression in healthy liver tissue (Figure 4). Upregulated
transcriptional levels of hepatic TLRs were also found when
comparing liver samples from AH with both SLAH/SOI and
POI forms of the infection. Thus, the AH stage livers had
significantly higher transcript levels of TLRs 2–5, 7, 8, and 10
(for all P < 0.05) compared to SLAH/SOI. AH livers also showed
higher expression of TLR2 (P < 0.05), TLR3 (P < 0.05), TLR7
(P < 0.05), TLR8 (P < 0.01), TLR9 (P < 0.01), and TLR10
(P < 0.01) when compared to those from POI. Furthermore,
livers from woodchucks with CH transcribed significantly more
TLR2 (P < 0.05), TLR3 (P < 0.05), TLR4 (P < 0.01), TLR6
(P< 0.001), TLR7 (P< 0.05), TLR8 (P< 0.01), TLR9 (P< 0.01),
and TLR10 (P < 0.01) than livers of healthy animals. Liver
biopsies from woodchucks with CH also had significantly greater
transcriptional levels of TLR2 (P< 0.05), TLR4 (P < 0.05), TLR6
(P < 0.05), TLR7 (P < 0.05), and TLR8 (P < 0.05) in relation to
the SLAH/SOI stage. Also, TLR2 (P < 0.05), TLR6 (P < 0.01),
TLR7 (P < 0.05), TLR8 (P < 0.01), TLR9 (P < 0.01), and TLR10
(P < 0.05) were transcribed at significantly higher levels in the
CH phase when compared to the liver tissue obtained during
POI (Figure 4). Finally, livers from POI had significantly higher
expression levels of TLR7 (P < 0.05) when compared to those
from the SLAH/SOI phase. TLR1 was undetectable in any of liver
biopsies examined. In summary, there was a trend toward an
overall increase in hepatic TLR expression when comparing liver
samples from PreAH, AH, and CH stages to those from animals
with SLAH/SOI or POI and healthy woodchucks.
The observed kinetics of TLRs 1–10 expression in sequential
liver biopsy and PBMC samples acquired from two male
woodchucks before inoculation with WHV and during
progression of infection from the pre-acute phase to CH
are shown in Supplementary Figure S5. These data illustrate
individual variations in the TLRs’ expression prior to and
during comparable stages of WHV infection. Thus, TLR2, TLR4,
TLR6, TLR9, and TLR 10 expression was not upregulated in
AH and/or CH comparing to healthy liver in woodchuck #1,
while upregulated TLR 2–9 expression during AH, but not
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FIGURE 5 | Profiles of TLR 1–10 expression in sequential PBMC samples
from healthy woodchucks and those with different forms of WHV infection and
hepatitis. Transcription levels of TLR 1–10 in PBMC acquired from healthy
animals (n = 11) and in different phases of WHV infection, including PreAH
(n = 8), AH (n = 18), SLAH/SOI (n = 6) and CH (n = 8). For details, see the
legend to Figure 3 and section “Materials and Methods”.
during CH, was found in woodchuck #2. It is of note that the
same two animals (plus others) also provided data included in
Figure 4. Together, the results indicate that although individual
animals may display variability in expression of certain TLRs
(Supplementary Figure S5), they also reveal that most of animal
groups with different forms of infection/hepatitis significantly
differed in their TLR expression patterns (Figure 4).
Expression of TLRs 1–10 in PBMC of
Healthy Animals and During Different
Forms of WHV Infection and Hepatitis
Sequential PBMC samples collected from healthy woodchucks
and during progression of WHV infection were evaluated for
the expression levels of TLRs 1–10 (Table 1). PBMC from
woodchucks with CH showed upregulated expression of several
TLRs when compared to the PBMC from healthy animals and
those from other study groups (Figure 5). When comparing to
PBMC from healthy woodchucks and those from animals with
SLAH/SOI, PBMC from CH had significantly higher expression
levels of TLR2 (P < 0.05) and TLR6 (P < 0.05). In addition,
they transcribed significantly higher levels of TLR2 (P < 0.05),
TLR6 (P < 0.01), TLR9 (P = 0.01), and TLR10 (P = 0.01)
in comparison to PBMC from AH (Figure 5). TLR8 was
significantly downregulated in the cells from SLAH/SOI when
compared to PBMC from the PreAH phase (P < 0.05) and
AH (P < 0.01). Whereas TLR3 had higher expression levels in
PBMC from the PreAH stage (P < 0.05) when compared to
the cells from AH. In contrast to liver and hepatocyte samples,
PBMC readily expressed TLR1, but the expression levels did
not significantly vary between healthy and woodchucks with
different forms of infection and stages of hepatitis. Overall, the
dynamic of expression of individual TLRs was noticeably less
pronounced in PBMC than in liver biopsies obtained from the
same stages of WHV infection and hepatitis, although there
was some compatibility observed. For example, expression of
TLR2 was significantly greater during CH than AH in both liver
biopsies and PBMC. In addition, significantly higher expression
of TLR6 in CH than in the period prior to infection, TLR8 in
AH than in the SLAH/SOI phase, and TLR10 in CH than in AH
were apparent in both PBMC and liver biopsies. Nonetheless, the
study uncovered that analysis of TLRs’ expression in PBMC does
not reflect reliably the liver profiles of TLRs’ transcription. An
example of TLRs 1–10 expression kinetics in sequential PBMC
and liver biopsy samples collected during progression of WHV
infection to CH is shown in Supplementary Figure S5.
DISCUSSION
The expression of TLRs 1–10 genes in livers, primary hepatocytes
and PBMC of healthy woodchucks and those with different
forms of experimental WHV infection and stages of hepatitis
was investigated in this study. To accomplish this, woodchuck
TLR 1–10 gene exon sequences were identified and primers
specific for TLRs 1–2 and 4–10 were designed. These primers,
together with woodchuck TLR3 primer pair previously reported
(Zhang et al., 2009), were optimized for specific amplification
of target sequences in RT-qPCR assays. To provide absolute
quantification, each TLR gene sequence was cloned and serial
dilutions of recombinant DNA sequences served as absolute
quantification standards. This facilitated enumeration of TLRs’
expression with high accuracy and sensitivity. Among the most
interesting findings of the study was identification that: (1)
certain profiles of TLRs’ expression tended to coincide with
particular forms of WHV infection; (2) analysis of the TLRs
transcription in hepatocytes provided more distinct association
with infection form than that of total liver tissue, as in case of
CH and SLAH/SOI, and (3) the profiles of TLRs’ expression
in PBMC rather poorly correlated with those of the liver and
hepatocytes observed in different forms of infection. In addition,
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this study for the first time established baseline TLRs’ expression
in healthy woodchucks and delineated the profiles of TLRs 1–10
transcription during progression of infection in the same animal
from the healthy state to CH or SLAH/SOI.
Studies on expression of TLR genes during HBV infection
were almost entirely limited to investigations of PBMC, as
acquisition of liver biopsies, particularly sequential samples,
from patients during progression of hepatitis B is essentially
not feasible (Akbal et al., 2017). In this context, woodchucks
experimentally infected with WHV offer an unmatched research
advantage by enabling collection of serial liver and PBMC
samples at experimentally defined time points post-infection
when the status of infection and liver disease can be accurately
determined. In the current study, samples collected from
WHV-infected woodchucks were representative of all forms of
infection and stages of hepatitis, as the data on serological
(i.e., immunovirological) markers, viral loads (Supplementary
Table S1) and liver histology attested.
Investigations of TLR transcription in healthy humans showed
that the liver was one of the organs transcribing TLRs at the
lowest levels (Zarember and Godowski, 2002; Nishimura and
Naito, 2005). This decreased basal hepatic TLRs’ expression
has been proposed to contribute to high immune tolerance to
intestinal antigens to which this organ is repetitively exposed
(Mencin et al., 2009). In contrast, human spleen and PBMC
have the highest expression levels of TLRs 1–10 among organs
tested (Zarember and Godowski, 2002). One study comparing
human PBMC to hepatic tissue has shown that all TLRs were
transcribed at a higher level in PBMC than in the liver, except
TLR3, when the levels were adjusted to house-keeping genes
including β-actin (Zarember and Godowski, 2002). In the current
study, mean TLR3 mRNA levels in normal woodchuck livers
also was greater than that in PBMC when related to the β-actin
expression (see Supplementary Figure S3). Nonetheless, this
difference was not observed when TLR3 expression was adjusted
to HPRT expression in the same locations (see Figure 1).
The same applied to expression of TLR2 and TLR4 after
adjustment to HPRT (Figure 1) instead of β-actin for which
liver showed significantly upregulated expression of both TLRs
when compared to lymphoid tissues (Supplementary Figure S3).
Notably, mean levels of TLR5 and TLR7 transcription in hepatic
tissue were consistently significantly greater than those in spleen
and PBMC of healthy animals after adjustment to either β-actin
or HPRT expression. This was in contrast to expression of
the same TLRs in humans where transcription levels were
significantly higher in spleen and PBMC than in livers (Zarember
and Godowski, 2002; Nishimura and Naito, 2005). However,
similar to human samples, TLR1 was expressed at significantly
greater levels in woodchuck PBMC and spleen than in livers
or isolated hepatocytes when adjusted to β-actin or HPRT
(see Supplementary Figure S3 and Figure 1, respectively). The
differences in expression of TLRs at basal (i.e., healthy state)
level between woodchucks and humans could be attributed to
species-specific differences, as reported in other species (Rehli,
2002; Heinz et al., 2003; Vaure and Liu, 2014; Perkins and Vogel,
2016). Overall, our study defined TLR 1–10 gene expressional
profiles in healthy woodchucks. This assessment established
baselines for comparative analyses of data from WHV-infected
animals. The relative limitation of our work was its focus on
evaluation of the TLR 1–10 genes’ transcription. However, this
type of analysis has been typically the first step in recognition
of contributions of different TLRs to immunological responses
and disease processes, and frequently proven to be a highly
valuable source of information that prompted further research
(e.g., Applequist et al., 2002; Zarember and Godowski, 2002;
Werling et al., 2017). In the case of the woodchuck-WHV model,
characterization of expression of multiple TLR proteins and their
responses to ligands and antagonists is not yet fully feasible due
to the lack of the majority of specific antibodies. This gap will
be likely filled up with time and together with the transcriptional
profiles delineated in this study provide more comprehensive
picture on the TLR involvement in the development, progression
and cessation of various forms of liver inflammation coinciding
with hepadnaviral infection.
The finding of significant differences in the TLR expression
profiles between livers and hepatocytes in some groups of
infected woodchucks was rather unexpected. This was somewhat
surprising since livers of healthy woodchucks and hepatocytes
isolated from them did no show significant differences in
the TLRs’ transcription, except TLR7; although non-significant
increases in the mean expression of other TLRs in hepatocytes
over livers were noted. Thus, when comparing TLRs’ expression
in paired livers and hepatocytes from animals with SLAH/SOI,
significantly lower mean levels of TLR3, TLR4, and TLR10
were identified in whole hepatic tissue than hepatocytes, while
mean TLR7 expression was significantly higher in livers than
hepatocytes (see Figure 3). Furthermore, hepatocytes from
SLAH/SOI displayed significantly greater mean transcription
levels of TLR3, TLR7, and TLR10 than hepatocytes from CH.
As indicated before, diagnosis of SLAH is considered when
serum WHsAg clears and biochemical markers of liver injury
normalize. This is accompanied by elimination or substantial
reduction of liver inflammation, as evidenced by histological and
immunohistochemical examinations, while WHV replication
persists for life at very low levels in both hepatocytes and the
immune system (Michalak et al., 1999; Guy et al., 2008). In
contrast, a consistent feature of CH is serum WHsAg-positivity,
high WHV loads in circulation and hepatocytes, and liver
necroinflammation associated with a variable degree of immune
cell infiltrations. These infiltrations are mainly composed of T
lymphocytes, which express mRNA and protein of most TLRs
(Rahman et al., 2009). In addition, B cells, monocytes and NK
and NK T cells may occur and they also express TLRs at relatively
high levels (Zarember and Godowski, 2002; Tu et al., 2008). In
this context, it might not be surprising that expression of certain
TLRs in SLAH/SOI was lower in liver tissue than hepatocytes,
as inflammatory immune cell infiltration has declined, while
hepatocytes in SLAH/SOI transcribed TLRs at greater levels than
those in CH in which viral replication and load are high. In
this regard, it has been reported that HBV is able to suppress
TLR-mediated pro-inflammatory and antiviral innate activities
in hepatocytes and non-parenchymal liver cells in mice (Wu
et al., 2009a,b). However, it remained unknown whether virus
directly inhibits TLR gene expression or acts on TLR signaling
Frontiers in Microbiology | www.frontiersin.org 12 December 2018 | Volume 9 | Article 3007
fmicb-09-03007 December 5, 2018 Time: 12:34 # 13
Williams et al. Woodchuck TLRs in Experimental Hepatitis
or other downstream pathways. The data from the current study
tend to suggest a direct effect of virus on TLRs’ transcription,
since the event occurred only in hepatocytes during CH, but
not SLAH/SOI where WHV occurs at very low levels (see
Supplementary Table S1) (Michalak et al., 1999). This may imply
that a high-grade of virus replication or its high intracellular
load may suppress TLRs. Another impacting factor could be the
degree and sites of WHV DNA integration into the hepatocellular
genome (Wei et al., 1992; Chauhan et al., 2017), as it was alluded
to, but not proved before (Wu et al., 2009a).
In an attempt to gain a better understanding of the TLR
transcriptional changes throughout the different stages of WHV
infection and hepatitis, serial liver biopsies collected from
animals prior to and after virus infection leading to AH followed
by CH or SLAH/SOI or after infection with very low doses of
virus causing POI were investigated. Detailed analysis of the
TLR expression profiles showed that when comparing pre-AH,
SLAH/SOI, and POI forms of infection and the healthy state
to AH and CH there was significant upregulation of almost
all TLRs in the livers from AH and CH stages (see Figure 4).
Intrahepatic inflammatory cell infiltrations peak at the time of
AH and continue during the course of CH in both humans and
woodchucks (Chisari and Ferrari, 1995; Hodgson and Michalak,
2001; Guy et al., 2008; Mani and Kleiner, 2009). In the current
study, there was no apparent relation between upregulated TLR
expression during AH and caseation of progression to CH, as
shown for two animals in Supplementary Figure S5. This raises
a possibility that other factors or receptors of the innate immune
response may be more important for resolution of hepadnaviral
AH. In this regard, our previous studies in the woodchuck model
showed that resolution of WHV-induced AH is predetermined
by a significantly greater hepatic expression of interferon gamma
(IFNγ) and CD3, an increased tumor necrosis alpha (TNFα)
transcription, low hepatic WHV load, and a greater degree of liver
inflammation than those in acute infection with CH outcome
(Hodgson and Michalak, 2001).
In liver biopsies from patients with CH type B, inflammatory
infiltrates contain around 75% T cells, 10% B cells and 10%
NK cells (Mani and Kleiner, 2009). This strongly suggests
that the augmented TLR expression in liver during CH is
most likely a consequence of increased TLR transcription
in immune cell infiltrates that occurs in the context of
downregulated transcription of the majority of TLRs in
hepatocytes. Interestingly, TLR1 was detectable in PBMC but not
in liver or hepatocytes and there was no significant difference
in its expression during the course of WHV infection. However,
it is feasible that TLR1 may be more functionally active as an
innate immune receptor in the periphery than in the intrahepatic
inflammatory infiltrates.
Activation of the innate immune system through
manipulating TLR signaling has been a focus in the development
of novel treatments against chronic viral infections, including
viral hepatitis. In the woodchuck model, the majority of studies
were directed toward manipulation of signaling of individual
TLRs. However, this took place with a lack of recognition of the
complexity of TLRs’ expressional interdependences in the liver
and expressional analysis of individual TLR genes in healthy
animals and in the course of WHV infection. Our study is the first
to delineate the profiles of TLR 1–10 gene transcription in the
liver, hepatocytes and PBMC in healthy woodchucks and those
with different forms of infection and stages of hepatitis. Similarly,
this study is the first to determine TLR1–10 expressional changes
chronologically in serial liver biopsies and PBMC obtained
throughout the course of WHV infection. The findings indicate
that restoration of hepatocyte TLR expression may be essential in
resolving CH. Restoring hepatocyte TLR function may promote
viral clearance and, in consequence, limit intrahepatic immune
cell infiltration and coinciding liver damage. Overall, the findings
of this study advance the understanding of the role of TLRs in
the course of hepadnaviral infection, particularly during CH.
They may contribute to the development of novel antiviral
treatments to allow for better control of the virus through
a stronger enhancement of intra-hepatocyte innate immune
response. Assessment of hepatic TLR expression could also serve
as an important biomarker to predict the efficacy of test antiviral
approaches and their effectiveness in resolving CH.
CONCLUSION
This study provides the first comprehensive determination of
TLR 1–10 expression profiles over the course of hepadnaviral
infection and in different forms of hepatitis in the woodchuck
HBV infection model. Analysis of serial liver biopsy and
PBMC samples and autopsy material demonstrated significantly
different TLRs’ expression patterns in distinct forms of
hepadnaviral infection and stages of hepatitis. It was also
uncovered that the TLR expression signatures displayed by liver
tissue do not follow those of hepatocytes in some stages of
hepatitis, particularly after resolution of acute infection when
secondary occult infection endures, and those of peripheral blood
mononuclear cells do not mirror accurately those of livers. These
findings should be of importance for the dissection of immune
process operating at different compartments naturally targeted by
hepadnavirus infection and for evaluation of therapies modifying
antiviral innate responses in the woodchuck model of hepatitis B
and liver cancer.
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